使用旅程映射进行向治疗的高级非小细胞肺癌患者的经验:一种定性研究
Hailing Tu1, Minghui Wang1, Shengmei Yang1
1School of Nursing, Anhui Medical University, 81# Meishan Road, Hefei 230032, China.
Current oncology (Toronto, Ont.)
|August 27, 2025
概括
这项研究对接受向治疗的晚期非小细胞肺癌 (NSCLC) 患者进行了绘制. 了解这些经验有助于医疗保健提供者及时提供支持并改善患者的生活质量.
科学领域:
- 癌症学
- 患者体验研究
- 质量健康研究
背景情况:
- 针对性治疗是高级非小细胞肺癌 (NSCLC) 的标准第一线治疗方法.
- 尽管癌症患者的生存率有所提高,
- 需要更深入地了解患者的经历,
研究的目的:
- 探索和描述接受向治疗的晚期NSCLC患者的经验.
- 制定患者旅程图,并确定不同治疗阶段的关键主题.
- 帮助开发有针对性的支持干预措施,提高患者的生活质量.
主要方法:
- 使用半结构面试对18名晚期NSCLC患者进行定性描述性研究.
- 用患者的旅程日志来补充采访数据.
- 创建了一个病人旅程地图, 概述了五个不同的治疗阶段.
主要成果:
- 患者的旅程分为五个阶段:诊断,初始治疗,维持治疗,疾病进展和生命结束.
- 在这些阶段, 患者体验有四个主要主题.
- 确定了特定的风险情况和支持干预的最佳时间.
结论:
- 医疗专业人员可以利用这些发现来主动识别需要支持的患者.
- 准备患者治疗过程和副作用可以减少焦虑并改善生活质量.
- 这项研究为改善晚期NSCLC的支持性护理提供了框架.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


